Return to search

Design Therapeutics snags $45m Series A

Design Therapeutics, which is developing treatments for serious degenerative disorders, has raised $45 million in Series A funding.

Design Therapeutics, which is developing treatments for serious degenerative disorders, has raised $45 million in Series A funding. SR One led the round with participation from Cormorant Asset Management, Quan Capital and WestRiver Group.

Source: Press Release